Pharmacoeconomics of Cholinesterase Inhibitors in the Treatment of Alzheimer’s Disease

Author： Jönsson L.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.21, Iss.14, 2003-01, pp. : 1025-1037

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer’s disease

By Martinez Ana   Castro Ana  

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 1, 2006-01 ,pp. : 1-12

Informa Healthcare

Access to resources Recommend Favorite

Cholinesterase Inhibitors Used in the Treatment of Alzheimer’s Disease: The Relationship Between Pharmacological Effects and Clinical Efficacy

By Wilkinson D.G.  

Drugs & Aging, Vol. 21, Iss. 7, 2004-01 ,pp. : 453-478

Adis International

Access to resources Recommend Favorite

The Role of Bridging Studies in the Development of Cholinesterase Inhibitors for Alzheimer’s Disease

By Cutler N.R.   Sramek J.J.  

CNS Drugs, Vol. 10, Iss. 5, 1998-11 ,pp. : 355-364

Adis International

Access to resources Recommend Favorite

Cholinesterase Inhibitors for the Treatment of Alzheimer's Disease in the Elderly

By vandenBerg C.M.   Kazmi Y.   Jann M.W.  

Drugs & Aging, Vol. 16, Iss. 2, 2000-02 ,pp. : 123-138

Adis International

Access to resources Recommend Favorite

Selectivity of Cholinesterase Inhibition: Clinical Implications for the Treatment of Alzheimer’s Disease

By Weinstock M.  

CNS Drugs, Vol. 12, Iss. 4, 1999-10 ,pp. : 307-323

Adis International

Access to resources Recommend Favorite